Pharma
AbbVie joins the weight loss race
In a $350m deal, AbbVie bought a Danish weight loss drug in Phase 1 clinical trials.
Metabolic Disease Drugs
Relevant stories on metabolic disease drugs focused on the business, policy, and technology developments happening behind the headlines.
Navigate the healthcare industry
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.
